An effective anti-viral approach targeting hepatitis B virus using NJK14047, a novel and selective biphenyl amide p38 MAPK inhibitor. [PublishAheadOfPrint]

Press/Media: Press / Media

Period2017 May 30

Media coverage

1

Media coverage